HK Stock MarketDetailed Quotes

YONGHE MEDICAL (02279)

Watchlist
  • 2.340
  • +0.020+0.86%
Market Closed May 14 16:04 CST
1.23BMarket Cap15.10P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

YONGHE MEDICAL (02279) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
0.21%1.81B
-4.29%861.55M
1.53%1.8B
8.75%900.2M
25.80%1.78B
10.65%827.81M
-34.85%1.41B
-28.98%748.14M
32.37%2.17B
75.11%1.05B
Operating income
0.21%1.81B
-4.29%861.55M
1.53%1.8B
8.75%900.2M
25.80%1.78B
10.65%827.81M
-34.85%1.41B
-28.98%748.14M
32.37%2.17B
75.11%1.05B
Cost of sales
14.74%-614.1M
16.06%-311.23M
7.66%-720.29M
-2.93%-370.77M
-44.40%-780.07M
-34.59%-360.21M
8.22%-540.21M
3.72%-267.64M
-41.26%-588.6M
-67.45%-277.98M
Operating expenses
14.74%-614.1M
16.06%-311.23M
7.66%-720.29M
-2.93%-370.77M
-44.40%-780.07M
-34.59%-360.21M
8.22%-540.21M
3.72%-267.64M
-41.26%-588.6M
-67.45%-277.98M
Gross profit
10.15%1.19B
3.94%550.32M
8.73%1.08B
13.22%529.44M
14.28%997.19M
-2.68%467.6M
-44.77%872.58M
-38.03%480.5M
29.33%1.58B
78.03%775.42M
Selling expenses
10.66%-806.15M
17.55%-381.41M
13.59%-902.39M
7.19%-462.57M
-36.20%-1.04B
-28.37%-498.4M
28.51%-766.78M
32.82%-388.25M
-37.59%-1.07B
-134.34%-577.95M
Administrative expenses
16.89%-237.09M
20.49%-112.09M
23.79%-285.26M
19.38%-140.97M
-45.35%-374.32M
-54.70%-174.86M
-4.03%-257.53M
-24.02%-113.03M
-52.78%-247.54M
-31.25%-91.14M
Research and development expenses
9.36%-19.26M
27.14%-9.05M
27.42%-21.25M
4.61%-12.43M
-58.31%-29.28M
-50.91%-13.03M
-30.59%-18.5M
-40.32%-8.63M
-19.87%-14.16M
-12.74%-6.15M
Impairment and provision
92.37%-4.62M
87.62%-1.75M
-113.16%-60.51M
-5,024.64%-14.14M
-20,469.57%-28.39M
-406.67%-276K
-190.20%-138K
123.94%90K
131.42%153K
-34.77%-376K
-Impairment of property, machinery and equipment
----
----
----
---14.06M
----
----
----
----
----
----
-Other impairment is provision
92.37%-4.62M
-2,088.75%-1.75M
-113.16%-60.51M
71.01%-80K
-20,469.57%-28.39M
-406.67%-276K
-190.20%-138K
123.94%90K
131.42%153K
-34.77%-376K
Special items of operating profit
78.47%-8.5M
95.58%-1.32M
24.90%-39.49M
-386.12%-29.97M
-701.25%-52.58M
-204.46%-6.17M
-15.25%8.75M
-36.83%5.9M
819.53%10.32M
311.79%9.34M
Operating profit
152.79%118.62M
134.21%44.7M
57.75%-224.69M
41.97%-130.65M
-229.01%-531.75M
-861.24%-225.13M
-163.11%-161.62M
-121.46%-23.42M
-3.82%256.1M
-0.17%109.15M
Financing income
-4.83%10.1M
6.48%5.88M
-16.42%10.62M
-27.19%5.52M
-87.71%12.7M
-88.13%7.59M
1,586.49%103.38M
2,553.45%63.9M
551.43%6.13M
1,004.59%2.41M
Financing cost
43.54%-23.27M
40.82%-12.77M
37.71%-41.22M
44.52%-21.57M
-29.17%-66.17M
-42.95%-38.88M
1.39%-51.23M
-19.94%-27.2M
-43.16%-51.95M
-41.68%-22.68M
Earning before tax
141.31%105.45M
125.77%37.81M
56.38%-255.29M
42.79%-146.7M
-434.61%-585.22M
-2,031.81%-256.43M
-152.06%-109.47M
-85.06%13.27M
-8.94%210.28M
-4.99%88.88M
Tax
-211.02%-31.89M
-223.64%-9.95M
-25.47%28.72M
-73.37%8.05M
63.23%38.54M
594.31%30.24M
126.21%23.61M
108.99%4.36M
-33.30%-90.09M
-72.47%-48.43M
After-tax profit from continuing operations
132.47%73.56M
120.09%27.86M
58.56%-226.57M
38.70%-138.65M
-536.73%-546.68M
-1,383.06%-226.19M
-171.44%-85.86M
-56.41%17.63M
-26.41%120.19M
-38.22%40.44M
Earning after tax
132.47%73.56M
120.09%27.86M
58.56%-226.57M
38.70%-138.65M
-536.73%-546.68M
-1,383.06%-226.19M
-171.44%-85.86M
-56.41%17.63M
-26.41%120.19M
-38.22%40.44M
Minority profit
34.07%-149K
23.68%-58K
22.07%-226K
---76K
---290K
----
----
----
----
----
Profit attributable to shareholders
132.57%73.71M
120.14%27.91M
58.58%-226.34M
38.74%-138.57M
-536.39%-546.39M
-1,383.06%-226.19M
-171.44%-85.86M
-56.41%17.63M
-26.41%120.19M
-38.22%40.44M
Basic earnings per share
133.33%0.15
121.43%0.06
58.33%-0.45
36.36%-0.28
-575.00%-1.08
-1,566.67%-0.44
-155.17%-0.16
-70.00%0.03
-25.64%0.29
-37.50%0.1
Diluted earnings per share
133.33%0.15
121.43%0.06
58.33%-0.45
36.36%-0.28
-575.00%-1.08
-1,566.67%-0.44
-157.14%-0.16
-70.00%0.03
-28.21%0.28
-37.50%0.1
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
PwC
--
PwC
--
PwC
--
PwC
--
PwC
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover 0.21%1.81B-4.29%861.55M1.53%1.8B8.75%900.2M25.80%1.78B10.65%827.81M-34.85%1.41B-28.98%748.14M32.37%2.17B75.11%1.05B
Operating income 0.21%1.81B-4.29%861.55M1.53%1.8B8.75%900.2M25.80%1.78B10.65%827.81M-34.85%1.41B-28.98%748.14M32.37%2.17B75.11%1.05B
Cost of sales 14.74%-614.1M16.06%-311.23M7.66%-720.29M-2.93%-370.77M-44.40%-780.07M-34.59%-360.21M8.22%-540.21M3.72%-267.64M-41.26%-588.6M-67.45%-277.98M
Operating expenses 14.74%-614.1M16.06%-311.23M7.66%-720.29M-2.93%-370.77M-44.40%-780.07M-34.59%-360.21M8.22%-540.21M3.72%-267.64M-41.26%-588.6M-67.45%-277.98M
Gross profit 10.15%1.19B3.94%550.32M8.73%1.08B13.22%529.44M14.28%997.19M-2.68%467.6M-44.77%872.58M-38.03%480.5M29.33%1.58B78.03%775.42M
Selling expenses 10.66%-806.15M17.55%-381.41M13.59%-902.39M7.19%-462.57M-36.20%-1.04B-28.37%-498.4M28.51%-766.78M32.82%-388.25M-37.59%-1.07B-134.34%-577.95M
Administrative expenses 16.89%-237.09M20.49%-112.09M23.79%-285.26M19.38%-140.97M-45.35%-374.32M-54.70%-174.86M-4.03%-257.53M-24.02%-113.03M-52.78%-247.54M-31.25%-91.14M
Research and development expenses 9.36%-19.26M27.14%-9.05M27.42%-21.25M4.61%-12.43M-58.31%-29.28M-50.91%-13.03M-30.59%-18.5M-40.32%-8.63M-19.87%-14.16M-12.74%-6.15M
Impairment and provision 92.37%-4.62M87.62%-1.75M-113.16%-60.51M-5,024.64%-14.14M-20,469.57%-28.39M-406.67%-276K-190.20%-138K123.94%90K131.42%153K-34.77%-376K
-Impairment of property, machinery and equipment ---------------14.06M------------------------
-Other impairment is provision 92.37%-4.62M-2,088.75%-1.75M-113.16%-60.51M71.01%-80K-20,469.57%-28.39M-406.67%-276K-190.20%-138K123.94%90K131.42%153K-34.77%-376K
Special items of operating profit 78.47%-8.5M95.58%-1.32M24.90%-39.49M-386.12%-29.97M-701.25%-52.58M-204.46%-6.17M-15.25%8.75M-36.83%5.9M819.53%10.32M311.79%9.34M
Operating profit 152.79%118.62M134.21%44.7M57.75%-224.69M41.97%-130.65M-229.01%-531.75M-861.24%-225.13M-163.11%-161.62M-121.46%-23.42M-3.82%256.1M-0.17%109.15M
Financing income -4.83%10.1M6.48%5.88M-16.42%10.62M-27.19%5.52M-87.71%12.7M-88.13%7.59M1,586.49%103.38M2,553.45%63.9M551.43%6.13M1,004.59%2.41M
Financing cost 43.54%-23.27M40.82%-12.77M37.71%-41.22M44.52%-21.57M-29.17%-66.17M-42.95%-38.88M1.39%-51.23M-19.94%-27.2M-43.16%-51.95M-41.68%-22.68M
Earning before tax 141.31%105.45M125.77%37.81M56.38%-255.29M42.79%-146.7M-434.61%-585.22M-2,031.81%-256.43M-152.06%-109.47M-85.06%13.27M-8.94%210.28M-4.99%88.88M
Tax -211.02%-31.89M-223.64%-9.95M-25.47%28.72M-73.37%8.05M63.23%38.54M594.31%30.24M126.21%23.61M108.99%4.36M-33.30%-90.09M-72.47%-48.43M
After-tax profit from continuing operations 132.47%73.56M120.09%27.86M58.56%-226.57M38.70%-138.65M-536.73%-546.68M-1,383.06%-226.19M-171.44%-85.86M-56.41%17.63M-26.41%120.19M-38.22%40.44M
Earning after tax 132.47%73.56M120.09%27.86M58.56%-226.57M38.70%-138.65M-536.73%-546.68M-1,383.06%-226.19M-171.44%-85.86M-56.41%17.63M-26.41%120.19M-38.22%40.44M
Minority profit 34.07%-149K23.68%-58K22.07%-226K---76K---290K--------------------
Profit attributable to shareholders 132.57%73.71M120.14%27.91M58.58%-226.34M38.74%-138.57M-536.39%-546.39M-1,383.06%-226.19M-171.44%-85.86M-56.41%17.63M-26.41%120.19M-38.22%40.44M
Basic earnings per share 133.33%0.15121.43%0.0658.33%-0.4536.36%-0.28-575.00%-1.08-1,566.67%-0.44-155.17%-0.16-70.00%0.03-25.64%0.29-37.50%0.1
Diluted earnings per share 133.33%0.15121.43%0.0658.33%-0.4536.36%-0.28-575.00%-1.08-1,566.67%-0.44-157.14%-0.16-70.00%0.03-28.21%0.28-37.50%0.1
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor PwC--PwC--PwC--PwC--PwC--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.66%
Sample Name
Sample Code
 +3.21%
Sample Name
Sample Code
 +1.57%
4
SINOPEC CORP
00386
+0.66%
5
CNOOC
00883
+0.53%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +47.30%
Sample Name
Sample Code
 +42.24%
Sample Name
Sample Code
 +30.17%
4
Loongson Technology Corporation
688047
+19.58%
5
Digital China Group
000034
+16.92%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -